电邮这篇文章 Simultaneous Determination of Metoprolol and Bisoprolol in Human Serum by HPLC-MS/MS for Clinical Drug Monitoring
- 作者: Rodina T.A.1,2, Mel’nikov E.S.2,3, Dmitriev A.I.2,3, Belkov S.A.1,2,3, Sokolov A.V.1,3, Arkhipov V.V.1,3, Prokof’ev A.B.1,2,3
-
隶属关系:
- Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
- I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
- 3I. M. Sechenov First Moscow State Medical University
- 期: 卷 51, 编号 12 (2018)
- 页面: 1111-1118
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244934
- DOI: https://doi.org/10.1007/s11094-018-1750-4
- ID: 244934
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
A method for simultaneous determination of metoprolol and bisoprolol in human blood serum by HPLC-MS/MS was developed and validated. The analytical ranges of the method were 5 – 250 ng/mL and 1 – 250 ng/mL for metoprolol and bisoprolol, respectively. The suitability of the developed for therapeutic drug monitoring during treatment for arterial hypertension and other cardiovascular diseases was demonstrated. In particular, the proposed method could identify patients at high risk for developing adverse effects and help to monitor a switch between metoprolol and bisoprolol while changing the pharmacotherapy regime.
作者简介
T. Rodina
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240
E. Mel’nikov
I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
A. Dmitriev
I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
S. Belkov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
A. Sokolov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
V. Arkhipov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
A. Prokof’ev
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
补充文件
